House bill · H.R. 4993 (119th Congress)

Joe Fiandra Access to Home Infusion Act of 2025

U.S. House of Representatives

Latest action Jan 12, 2026

Sponsor: Brian K. Fitzpatrick (U.S. Representative, PA-1, Republican)

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Sep 8, 2026. About our data

Summary

Joe Fiandra Access to Home Infusion Act of 2025 This bill provides for Medicare coverage of certain home infusion drugs that are administered by health care professionals at a beneficiary’s home. Specifically, the bill provides for coverage of external infusion pumps and associated home infusion drugs for which (1) the prescription requires that the drug be administered by or under the supervision of a health care professional, (2) a qualified home infusion therapy supplier administers or supervises the administration of the drug at the beneficiary's home, and (3) the prescription requires that the drug be infused at least 12 times per year in a manner that requires the use of an external infusion pump.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Out of committee and scheduled for a vote by the full chamber.

Introduced
In committee
Up for a vote
Passed one chamber
Passed
Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Also referred to House Committee on Ways and Means · U.S. House of Representatives.

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

Cosponsors listed on Congress.gov, shown A to Z.

Democratic4
Republican2

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

As identified by Congress.gov.

Full history

Jan 12, 2026
Introduced
Introduced in U.S. House
U.S. House
Dec 10, 2025
Committee vote
Committee Consideration and Mark-up Session Held
Dec 10, 2025
Committee vote
Committee Consideration and Mark-up Session Held
Dec 10, 2025
Committee vote
Committee Consideration and Mark-up Session Held
Dec 10, 2025
Reported out of committee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.

Show full history (7 earlier events)

Dec 10, 2025
Introduced
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
U.S. House
Dec 10, 2025
Reported out of committee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
Dec 10, 2025
Reported out of committee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
Aug 19, 2025
Introduced
Introduced in House
U.S. House of Representatives
Aug 19, 2025
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Aug 19, 2025
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Aug 19, 2025
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Read the record

Read on Congress.gov (opens in a new tab) The official record on Congress.gov.